IN THE UNITED STATES PATENT AND TRADEMARK OFFICE

Application No.:	Case Data/Diary Field/Basic Application No.
Confirmation No.:	Confirmation
First-Named Inventor:	Inventor 
Filing Date:	Case Data/Diary Field/Basic Application Date 
Group Art Unit:	GAU
Examiner:	Examiner 
Attorney Docket No.:	Matter No.
Title:	TITLE 

INFORMATION DISCLOSURE STATEMENT TRANSMITTAL

1.	List of All Patents, Publications, U.S. Applications, or Other Information

	Pursuant to the provisions of 37 C.F.R. §§ 1.56, 1.97, and 1.98, applicant requests consideration of the references listed on the attached PTO/SB/08 form(s) [commonly referred to as a PTO-1449 form] and/or the additional information identified below. 

2.	Enclosed Legible Copies

	2a.	A legible copy of each foreign patent document and publication listed on the PTO/SB/08 form is enclosed:

		i.	except, pursuant to MPEP 609.02, a copy is not provided for each reference previously cited by or submitted to the Patent Office in prior US Patent Application No(s).                                , filed                                 from which the present application claims priority under 35 U.S.C. § 120.

		ii.	except, a copy is not provided for each cumulative reference and enclosed reference identified below:
			     

	2b.	A copy of the specification and drawings for each cited unpublished U.S. application.

	2c.	A copy of a Search Report or Written Opinion from a foreign patent office is also enclosed.

	2d.	Consideration of the enclosed additional and/or below discussed information is requested.

3.	Concise Explanation of Relevance for Non-English Language Information

For each non-English language reference listed on the attached PTO/SB/08 form(s), reference is made to:

	3a.	an English language translation submitted herewith,

	3b.	a foreign patent office Search Report (in the English language) submitted herewith,

	3c.	an English language translation of a foreign patent office Search Report submitted herewith,

	3d.	the concise explanation contained in the present application at page(s)      ,

	3e.	the concise explanation set forth in the attached English language abstract,

	3f.	a copy of a related patent publication (in the English language) cited herewith,

Foreign Patent Document
Corresponding English Language  Patent Document



	3g.	the following concise explanation:       .

4.	Time for Filing

	4a.	This Information Disclosure Statement is submitted: 
	
		i.	for U.S. national applications or national stage PCT applications (not including CPAs and RCEs), within three months of filing or entry into national stage;

		ii.	for U.S. national applications, national stage PCT applications, CPAs, or RCEs before the first Office Action on the merits; and/or

		iii.	before the mailing of an Office Action on the merits after the filing of a Request for Continued Examination (RCE) under § 1.114,
 
	and thus no certification and/or fee is required.

	4b.	This information Disclosure Statement is submitted after three months from the filing date and after the first Office Action on the merits but prior to the mailing date of a final Office Action or Notice of Allowance, and thus:

		i.	the statement specified in 37 C.F.R. § 1.97(e) is provided below, or

		ii.	the fee set forth in 37 C.F.R. § 1.17(p) is enclosed.

	4c.	This Information Disclosure Statement is submitted after the mailing date of a final Office Action or Notice of Allowance and prior to payment of the issue fee, and thus:

		i.	the statement specified in 37 C.F.R. § 1.97(e) is provided below and the fee set forth in 37 C.F.R. § 1.17(p) is enclosed, or

		ii.	a Request for Continued Examination (RCE) and fee of 37 C.F.R. § 1.17(e) has been filed.

	4d.	This Information Disclosure Statement is submitted after payment of the issue fee, and thus:

		i.	a Petition to Withdraw from Issue pursuant to 37 C.F.R. § 1.313(c)(2) has been filed, and

		ii.	a Request for Continued Examination (RCE) and fee of 37 C.F.R. § 1.17(e) has been filed.

5.	Certification- Statement Under 37 C.F.R. 1.97(e)
	
	5a.	It is hereby certified that each item of information contained in this Information Disclosure Statement was first cited in any communication from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of this Information Disclosure Statement.

	5b.	It is hereby certified that no item of information contained in this Information Disclosure Statement was cited in a communication from a foreign patent office in a counterpart foreign application and, to my knowledge after making reasonable inquiry, no item of information contained in this Information Disclosure Statement was known to any individual designated in § 1.56(c) more than three months prior to the filing of this Information Disclosure Statement.
The filing of this Information Disclosure Statement shall not be construed as an admission that the information cited is, or is considered to be, material to patentability as defined in § 1.56(b).  It is believed that no additional fees are required.  Should any other fee be required, however, please charge such fee to Deposit Account No. 23-3030, but not to include any payment of issue fees.

	Respectfully submitted,



	By	__________________________________________
		Attorney, Reg. No. Number
		Wilson, Ellis, Merton, Mallock & Harold LLP
		111 Courthouse Circle, Suite 101
		Philadelphia, Pennsylvania 19103-5137
		Telephone:  (215) 634-3456     Fax:  (215) 637-7561
		Email:  Attorney Email
